Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Jean-Jacques Lafitte"'
Autor:
Luigi Moretti, Anne-Pascale Meert, Nicolas Girard, Jean-Jacques Lafitte, Christiane Jungels, Valérie Durieux, Martine Roelandts, Thierry Berghmans, Stéphane Holbrechts, Sebahat Ocak
Publikováno v:
Lung cancer, Vol. 126, p. 25-31 (2018)
Thymic tumours are rare diseases that for most of the cases are cured with surgery and eventually adjuvant radiotherapy. However, about 30% of patients present with advanced stage or relapsing tumours, which require administration of chemotherapy. Wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff8b4447e4ba813e9f746a0510da31d4
https://hdl.handle.net/2078.1/208839
https://hdl.handle.net/2078.1/208839
Autor:
Arnaud Scherpereel, Thierry Berghmans, Alexis B. Cortot, Céline Mascaux, Jean-Paul Sculier, Ingrid CsToth, Lieveke Ameye, Marianne Paesmans, Luc Willems, Anne-Pascale Meert, L Toussaint, Nathalie Leclercq, Tiffany Dernies, Jean-Jacques Lafitte
Publikováno v:
Lung Cancer. 82:340-345
Clinical variables, like stage and performance status (PS), have predictive and prognostic values in advanced non-small cell lung cancer (NSCLC) patients treated with chemotherapy, not allowing adequate individual prediction. MicroRNA (miRNA) are non
Autor:
Jean-Jacques Lafitte, Gregory Petyt, Stefanie Habib, Julie Delourme, Alexis B. Cortot, Nunzia Tacelli, Arnaud Scherpereel, Xavier Dhalluin
Publikováno v:
Lung Cancer. 80:197-202
Background Combination of bevacizumab and weekly paclitaxel showed synergitic effects, anti-tumor efficacy and a good toxicity profile for patients with breast cancer but has never been evaluated in non small cell lung cancer (NSCLC). We retrospectiv
Autor:
Anne-Pascale Meert, Olivier Van Cutsem, Vicente Giner, Martine Roelandts, Nathalie Leclercq, Yves Bonduelle, Arnaud Scherpereel, Thierry Berghmans, Benoit Colinet, Jean-Paul Sculier, Jean-Jacques Lafitte, Paul Van Houtte, Marianne Paesmans
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 117
Objectives To assess if induction radiochemotherapy followed by consolidation chemotherapy (arm A) will improve survival in comparison with the same chemotherapy given as induction followed by consolidation concurrent radiochemotherapy (arm B) in pat
Autor:
Thierry, Berghmans, Delphine, Gourcerol, Jean-Jacques, Lafitte, Katerina, Kotsori, Marianne, Paesmans, Arnaud, Scherpereel, Nathalie, Leclercq, Jean-Paul, Sculier, J P, Bervar
Publikováno v:
Lung Cancer. 61:378-384
Summary We aimed to evaluate, in a phase II study, the efficacy of the mitomycin–vinorelbine combination in non-small cell lung cancer (NSCLC) patients, relapsing after taxane-based regimens, a situation in which no standard chemotherapy is current
Autor:
George Koumakis, Jacques Thiriaux, Jean-Paul Sculier, Thierry Berghmans, V. Giner, P. VanHoutte, Peggy Wackenier, P. Lothaire, Paul Mommen, Jean-Jacques Lafitte, Michel Richez, J.-L. Corhay, Anna Efremidis, J. Lecomte, Vincent Ninane
Publikováno v:
Lung Cancer. 45:339-348
The 1997 International staging system (ISS) classification separated stage III non-small cell lung cancer (NSCLC) into stages IIIA and IIIB. In a previous study including unresectable NSCLC initially treated with chemotherapy, we analysed survival ac
Autor:
Constantinos Alexopoulos, Vincent Ninane, M.C. Florin, Paul Mommen, Jacques Thiriaux, P Recloux, Anna Efremidis, J. Lecomte, Thierry Berghmans, Jean Klastersky, Marianne Paesmans, Jean-Jacques Lafitte, Jean-Paul Sculier
Publikováno v:
Annals of Oncology. 13:874-882
Objective To determine, in stage IV non-small-cell lung cancer (NSCLC), if the combination of gemcitabine—a new active drug—with ifosfamide (IG) or with the cisplatin-carboplatin association (CCG) will improve survival (primary end point) in comp
Autor:
M.C. Berchier, Marianne Paesmans, J. Michel, Thierry Berghmans, J. Lecomte, V. Giner, George Koumakis, Jean Klastersky, Jean-Jacques Lafitte, Jean-Paul Sculier, Jacques Thiriaux, Vincent Ninane, M.C. Florin, Paul Mommen, O Van Cutsem
Publikováno v:
British Journal of Cancer
British Journal of Cancer, 85 (10
British Journal of Cancer, 85 (10
SCOPUS: ar.j
info:eu-repo/semantics/published
info:eu-repo/semantics/published
Autor:
Thierry, Berghmans, Jean-Jacques, Lafitte, Arnaud, Scherpereel, Marianne, Paesmans, Jacques, Lecomte, Vicente Giner, Marco, Anne-Pascale, Meert, Nathalie, Leclercq, Jean-Paul, Sculier
Publikováno v:
Anticancer research. 33(12)
While meta-analyses and clinical trials show improved survival in advanced NSCLC treated with platinum-containing chemotherapy, there are few data concerning front-line platinum-free ifosfamide-based regimens. We aimed to compare cisplatin-based chem
Autor:
Marianne Paesmans, Paul Mommen, Jacqueline Schmerber, M.C. Florin, Jean-Jacques Lafitte, Jean-Paul Sculier, Thierry Berghmans, J. Baumöhl, Constantinos Zacharias, George Koumakis, Vincent Ninane, Constantinos Alexopoulos, Jean Klastersky, Jacques Thiriaux
Publikováno v:
British Journal of Cancer
A phase III randomized trial was conducted in patients with metastatic NSCLC, to determine if, in association with mitomycin (6 mg m–2) and ifosfamide (3 g m–2), the combination of moderate dosages of cisplatin (60 mg m–2) and carboplatin (200